A landmark study by Hyderabad’s L V Prasad Eye Institute (LVPEI), published in the British Journal of Ophthalmology, has ...

Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...

Going for a regular eye check-up is about more than assessing your ability to see. Your eyes can be a window to early ...

Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred. Known as the “silent thief of sight,” the disease ...

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

BOZEMAN, MT – November 04, 2025 – PRESSADVANTAGE – Glaucoma continues to be one of the most significant causes of vision loss across the country, often developing slowly and without obvious warning ...

While the tumours caused by NF2 are benign, where they are located and their size can lead to debilitating effects. Read more ...

Scientists have created an advanced visual neuroprosthesis that communicates bidirectionally with the brain, marking one of the biggest steps yet toward restoring functional vision.

A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...